+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 80Years
All Genders
ID06316895

Clinical Outcomes and AI Prediction for Ultrasound-guided Thermal Ablation and Surgery in Low-risk Papillary Thyroid Cancer

Led by Chinese PLA General Hospital · Updated on 2026-03-20

3772

Participants Needed

1

Research Sites

143 weeks

Total Duration

AI-Summary

What this Trial Is About

Researchers are evaluating the clinical outcomes of ultrasound-guided thermal ablation compared to thyroid surgery for treating low-risk papillary thyroid carcinoma. The study also aims to develop and validate an artificial intelligence model to predict the results of thermal ablation in this condition. This observational study focuses on patients with small tumors and no evidence of cancer spread. Participants choose between two treatment groups thyroid surgery, which involves a thyroid lobectomy, or ultrasound-guided thermal ablation using radiofrequency, microwave, or laser techniques. The study follows patients over time to assess disease progression and treatment effects. During the study, participants will be monitored for at least 12 months. Researchers will track the rate of disease progression over more than 5 years as the primary outcome. Secondary outcomes include rates of complications within 1 week and tumor disappearance within 2 years. Evaluations will involve imaging and clinical assessments to measure these outcomes.

CONDITIONS

Brief Title

The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma

Research Team

L

Lin Yan, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here